Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study (2020)
- Authors:
- USP affiliated authors: FORLENZA, ORESTES VICENTE - FM ; GATTAZ, WAGNER FARID - FM
- Unidade: FM
- DOI: 10.1007/s00406-019-01034-9
- Subjects: METABOLÔMICA; TRANSTORNOS COGNITIVOS; BIOMARCADORES; DOENÇA DE ALZHEIMER; ENVELHECIMENTO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2020
- Source:
- Título do periódico: European archives of psychiatry and clinical neuroscience
- ISSN: 0940-1334
- Volume/Número/Paginação/Ano: v. 270, n. 4, p. 483-488, 2020
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
COSTA, Alana C. et al. Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study. European archives of psychiatry and clinical neuroscience, v. 270, n. 4, p. 483-488, 2020Tradução . . Disponível em: https://doi.org/10.1007/s00406-019-01034-9. Acesso em: 27 abr. 2024. -
APA
Costa, A. C., Joaquim, H. P. G., Forlenza, O. V., Gattaz, W. F., & Talib, L. L. (2020). Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study. European archives of psychiatry and clinical neuroscience, 270( 4), 483-488. doi:10.1007/s00406-019-01034-9 -
NLM
Costa AC, Joaquim HPG, Forlenza OV, Gattaz WF, Talib LL. Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study [Internet]. European archives of psychiatry and clinical neuroscience. 2020 ; 270( 4): 483-488.[citado 2024 abr. 27 ] Available from: https://doi.org/10.1007/s00406-019-01034-9 -
Vancouver
Costa AC, Joaquim HPG, Forlenza OV, Gattaz WF, Talib LL. Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study [Internet]. European archives of psychiatry and clinical neuroscience. 2020 ; 270( 4): 483-488.[citado 2024 abr. 27 ] Available from: https://doi.org/10.1007/s00406-019-01034-9 - Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression
- Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein
- Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease
- Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease
- Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease
- Mild cognitive impairment (part 2): biological markers for diagnosis and prediction of dementia in Alzheimer's disease
- Long-term, low-dose lithium treatment does not impair renal functional in the elderly: A 2 year randomized, placebo-controlled trial followed by single blind extension
- Low Doses of Lithium Changes PKA, AKT and Tau Protein in Cortical and Hippocampal Neurons Cell Culture
- Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study
- A radioenzymatic assay to identify three groups of phospholipase A2 in platelets
Informações sobre o DOI: 10.1007/s00406-019-01034-9 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
